- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07306897
Postoperative Pulmonary Complications in Elderly Patients Undergoing Major Abdominal Surgery (PPC65MAS)
Risk Factors for Postoperative Pulmonary Complications After Major Abdominal Surgery in Patients Aged 65 Years and Older: A Retrospective Observational Study
This study aims to identify the risk factors associated with postoperative pulmonary complications (PPCs) in patients aged 65 years and older who undergo major abdominal surgery.
The study is designed as a retrospective observational analysis using data from patient records.
Understanding these risk factors may help clinicians improve perioperative care and reduce the risk of respiratory problems after surgery in elderly patients.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ankara
-
Ankara, Ankara, Turkey (Türkiye), 06370
- Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients aged 65 years or older.
- Patients who underwent major abdominal surgery at [Institution Name].
- Availability of complete perioperative and postoperative clinical records.
- Postoperative hospital stay of at least 24 hours.
Exclusion Criteria:
- Patients younger than 65 years.
- Patients undergoing minor or non-abdominal surgery.
- Incomplete or missing perioperative or postoperative medical records.
- Patients who underwent emergency surgery
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Group 1: Patients with postoperative pulmonary complications (PPC +)
Group 1 - Patients with postoperative pulmonary complications (PPC +): This group includes patients aged 65 years and older who underwent major abdominal surgery and developed one or more postoperative pulmonary complications, as defined by EPCO criteria |
|
Group 2: Patients without postoperative pulmonary complications (PPC -)
Group 2 - Patients without postoperative pulmonary complications (PPC -): This group includes patients aged 65 years and older who underwent major abdominal surgery but did not develop any postoperative pulmonary complications. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Postoperative Pulmonary Complications
Time Frame: Within 1 day after surgery
|
The primary outcome is the occurrence of one or more postoperative pulmonary complications (PPCs) in patients aged 65 years and older undergoing major abdominal surgery.
PPCs include pneumonia, respiratory failure, or need for reintubation, as defined by the European Perioperative Clinical Outcome (EPCO) criteria.
Data were collected retrospectively from patient records during the postoperative hospital stay.
|
Within 1 day after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Arif Timuroğlu, ankara oncology trainig and research hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PPC65-MAS-2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityWithdrawnHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Universidad de la SabanaClínica Universidad de La Sabana; Universidad de La Sabana, ColombiaCompletedPneumococcal Pneumonia | Community Acquired Pneumonia (CAP)Colombia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
Hu YinanEnrolling by invitationSialic Acid | Superoxide Dismutase | Lipid PneumoniaChina
-
ShionogiCompletedHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine